Seeing Is Believing
Currently out of the existing stock ratings of Roger Song, 25 are a BUY (80.65%), 5 are a HOLD (16.13%), 1 are a SELL (3.23%).
Analyst Roger Song works at JEFFERIES with a stock forecast success ratio of 19.23% fulfilled within 57.23 days on average.
Roger Song’s has documented 63 price targets and ratings displayed on 15 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CTMX, CytomX Therapeutics at 06-May-2024.
Analyst best performing recommendations are on NKTR (NEKTAR THERAPEUTICS).
The best stock recommendation documented was for NKTR (NEKTAR THERAPEUTICS) at 5/31/2022. The price target of $4 was fulfilled within 23 days with a profit of $0.52 (14.94%) receiving and performance score of 6.5.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
1
$0.7 (233.33%)
4
8 months 23 days ago
0/6 (0%)
$0.49 (96.08%)
Hold
1
$0.7 (233.33%)
4
8 months 26 days ago
0/6 (0%)
$0.44 (78.57%)
Buy
25
8 months 26 days ago
0/4 (0%)
$18.48 (1258.95%)
Buy
20
1 years 1 months 6 days ago
1/3 (33.33%)
$14.51 (264.30%)
220
Buy
27
1 years 11 months 18 days ago
0/1 (0%)
$18.23 (207.87%)
Which stock is Roger Song is most bullish on?
Which stock is Roger Song is most reserved on?
What Year was the first public recommendation made by Roger Song?